4//SEC Filing
Janssen Robert 4
Accession 0001029142-25-000020
CIK 0001029142other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:57 PM ET
Size
8.4 KB
Accession
0001029142-25-000020
Insider Transaction Report
Form 4
Janssen Robert
Chief Medical Officer and VP
Transactions
- Exercise/Conversion
Common Stock
2025-02-10+4,333→ 63,017 total - Exercise/Conversion
Restricted Stock Unit
2025-02-10−4,333→ 0 total→ Common Stock (4,333 underlying) - Tax Payment
Common Stock
2025-02-10$13.20/sh−1,781$23,509→ 61,236 total
Footnotes (2)
- [F1]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022.
- [F2]Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.
Documents
Issuer
DYNAVAX TECHNOLOGIES CORP
CIK 0001029142
Entity typeother
Related Parties
1- filerCIK 0001580849
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:57 PM ET
- Size
- 8.4 KB